Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Transforming Growth Factor Beta 1 Market Growth 2022-2028

  • LP 4700860
  • 100 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Transforming Growth Factor Beta 1 will have significant change from previous year. According to our (LP Information) latest study, the global Transforming Growth Factor Beta 1 market size is USD million in 2022 from USD 1426.5 million in 2021, with a change of % between 2021 and 2022. The global Transforming Growth Factor Beta 1 market size will reach USD 3059.1 million in 2028, growing at a CAGR of 11.5% over the analysis period.

The United States Transforming Growth Factor Beta 1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transforming Growth Factor Beta 1 market, reaching US$ million by the year 2028. As for the Europe Transforming Growth Factor Beta 1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Transforming Growth Factor Beta 1 players cover Roche, Shionogi Ltd, Acceleron Pharma Inc, and Genzyme Corp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Transforming Growth Factor Beta 1 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Pirfenidone

Galunisertib

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

IPF

Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Roche

Shionogi Ltd

Acceleron Pharma Inc

Genzyme Corp

Isarna Therapeutics GmbH

Scholar Rock

Sirnaomics Inc

Eli Lilly and Co

Formation Biologics Inc

Novartis AG

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Transforming Growth Factor Beta 1 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Transforming Growth Factor Beta 1 by Country/Region, 2017, 2022 & 2028

2.2 Transforming Growth Factor Beta 1 Segment by Type

2.2.1 Pirfenidone

2.2.2 Galunisertib

2.2.3 Others

2.3 Transforming Growth Factor Beta 1 Sales by Type

2.3.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)

2.3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Transforming Growth Factor Beta 1 Sale Price by Type (2017-2022)

2.4 Transforming Growth Factor Beta 1 Segment by Application

2.4.1 IPF

2.4.2 Cancer

2.4.3 Others

2.5 Transforming Growth Factor Beta 1 Sales by Application

2.5.1 Global Transforming Growth Factor Beta 1 Sale Market Share by Application (2017-2022)

2.5.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Transforming Growth Factor Beta 1 Sale Price by Application (2017-2022)

3 Global Transforming Growth Factor Beta 1 by Company

3.1 Global Transforming Growth Factor Beta 1 Breakdown Data by Company

3.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Company (2020-2022)

3.1.2 Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2020-2022)

3.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Company (2020-2022)

3.2.1 Global Transforming Growth Factor Beta 1 Revenue by Company (2020-2022)

3.2.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2020-2022)

3.3 Global Transforming Growth Factor Beta 1 Sale Price by Company

3.4 Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Transforming Growth Factor Beta 1 Product Location Distribution

3.4.2 Players Transforming Growth Factor Beta 1 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Transforming Growth Factor Beta 1 by Geographic Region

4.1 World Historic Transforming Growth Factor Beta 1 Market Size by Geographic Region (2017-2022)

4.1.1 Global Transforming Growth Factor Beta 1 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Geographic Region

4.2 World Historic Transforming Growth Factor Beta 1 Market Size by Country/Region (2017-2022)

4.2.1 Global Transforming Growth Factor Beta 1 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Transforming Growth Factor Beta 1 Annual Revenue by Country/Region

4.3 Americas Transforming Growth Factor Beta 1 Sales Growth

4.4 APAC Transforming Growth Factor Beta 1 Sales Growth

4.5 Europe Transforming Growth Factor Beta 1 Sales Growth

4.6 Middle East & Africa Transforming Growth Factor Beta 1 Sales Growth

5 Americas

5.1 Americas Transforming Growth Factor Beta 1 Sales by Country

5.1.1 Americas Transforming Growth Factor Beta 1 Sales by Country (2017-2022)

5.1.2 Americas Transforming Growth Factor Beta 1 Revenue by Country (2017-2022)

5.2 Americas Transforming Growth Factor Beta 1 Sales by Type

5.3 Americas Transforming Growth Factor Beta 1 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Transforming Growth Factor Beta 1 Sales by Region

6.1.1 APAC Transforming Growth Factor Beta 1 Sales by Region (2017-2022)

6.1.2 APAC Transforming Growth Factor Beta 1 Revenue by Region (2017-2022)

6.2 APAC Transforming Growth Factor Beta 1 Sales by Type

6.3 APAC Transforming Growth Factor Beta 1 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Transforming Growth Factor Beta 1 by Country

7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country (2017-2022)

7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country (2017-2022)

7.2 Europe Transforming Growth Factor Beta 1 Sales by Type

7.3 Europe Transforming Growth Factor Beta 1 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Transforming Growth Factor Beta 1 by Country

8.1.1 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2017-2022)

8.2 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type

8.3 Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1

10.3 Manufacturing Process Analysis of Transforming Growth Factor Beta 1

10.4 Industry Chain Structure of Transforming Growth Factor Beta 1

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Transforming Growth Factor Beta 1 Distributors

11.3 Transforming Growth Factor Beta 1 Customer

12 World Forecast Review for Transforming Growth Factor Beta 1 by Geographic Region

12.1 Global Transforming Growth Factor Beta 1 Market Size Forecast by Region

12.1.1 Global Transforming Growth Factor Beta 1 Forecast by Region (2023-2028)

12.1.2 Global Transforming Growth Factor Beta 1 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Transforming Growth Factor Beta 1 Forecast by Type

12.7 Global Transforming Growth Factor Beta 1 Forecast by Application

13 Key Players Analysis

13.1 Roche

13.1.1 Roche Company Information

13.1.2 Roche Transforming Growth Factor Beta 1 Product Offered

13.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Roche Main Business Overview

13.1.5 Roche Latest Developments

13.2 Shionogi Ltd

13.2.1 Shionogi Ltd Company Information

13.2.2 Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered

13.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Shionogi Ltd Main Business Overview

13.2.5 Shionogi Ltd Latest Developments

13.3 Acceleron Pharma Inc

13.3.1 Acceleron Pharma Inc Company Information

13.3.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered

13.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Acceleron Pharma Inc Main Business Overview

13.3.5 Acceleron Pharma Inc Latest Developments

13.4 Genzyme Corp

13.4.1 Genzyme Corp Company Information

13.4.2 Genzyme Corp Transforming Growth Factor Beta 1 Product Offered

13.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Genzyme Corp Main Business Overview

13.4.5 Genzyme Corp Latest Developments

13.5 Isarna Therapeutics GmbH

13.5.1 Isarna Therapeutics GmbH Company Information

13.5.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered

13.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Isarna Therapeutics GmbH Main Business Overview

13.5.5 Isarna Therapeutics GmbH Latest Developments

13.6 Scholar Rock

13.6.1 Scholar Rock Company Information

13.6.2 Scholar Rock Transforming Growth Factor Beta 1 Product Offered

13.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Scholar Rock Main Business Overview

13.6.5 Scholar Rock Latest Developments

13.7 Sirnaomics Inc

13.7.1 Sirnaomics Inc Company Information

13.7.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered

13.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Sirnaomics Inc Main Business Overview

13.7.5 Sirnaomics Inc Latest Developments

13.8 Eli Lilly and Co

13.8.1 Eli Lilly and Co Company Information

13.8.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered

13.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eli Lilly and Co Main Business Overview

13.8.5 Eli Lilly and Co Latest Developments

13.9 Formation Biologics Inc

13.9.1 Formation Biologics Inc Company Information

13.9.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered

13.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Formation Biologics Inc Main Business Overview

13.9.5 Formation Biologics Inc Latest Developments

13.10 Novartis AG

13.10.1 Novartis AG Company Information

13.10.2 Novartis AG Transforming Growth Factor Beta 1 Product Offered

13.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis AG Main Business Overview

13.10.5 Novartis AG Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Transforming Growth Factor Beta 1 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Transforming Growth Factor Beta 1 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Pirfenidone

Table 4. Major Players of Galunisertib

Table 5. Major Players of Others

Table 6. Global Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)

Table 7. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)

Table 8. Global Transforming Growth Factor Beta 1 Revenue by Type (2017-2022) & ($ million)

Table 9. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2022)

Table 10. Global Transforming Growth Factor Beta 1 Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)

Table 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)

Table 13. Global Transforming Growth Factor Beta 1 Revenue by Application (2017-2022)

Table 14. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2017-2022)

Table 15. Global Transforming Growth Factor Beta 1 Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Transforming Growth Factor Beta 1 Sales by Company (2020-2022) & (K Units)

Table 17. Global Transforming Growth Factor Beta 1 Sales Market Share by Company (2020-2022)

Table 18. Global Transforming Growth Factor Beta 1 Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company (2020-2022)

Table 20. Global Transforming Growth Factor Beta 1 Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Transforming Growth Factor Beta 1 Producing Area Distribution and Sales Area

Table 22. Players Transforming Growth Factor Beta 1 Products Offered

Table 23. Transforming Growth Factor Beta 1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Transforming Growth Factor Beta 1 Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Transforming Growth Factor Beta 1 Sales Market Share Geographic Region (2017-2022)

Table 28. Global Transforming Growth Factor Beta 1 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Transforming Growth Factor Beta 1 Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Transforming Growth Factor Beta 1 Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Transforming Growth Factor Beta 1 Sales Market Share by Country/Region (2017-2022)

Table 32. Global Transforming Growth Factor Beta 1 Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Transforming Growth Factor Beta 1 Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)

Table 35. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country (2017-2022)

Table 36. Americas Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country (2017-2022)

Table 38. Americas Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)

Table 39. Americas Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)

Table 40. Americas Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)

Table 41. Americas Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)

Table 42. APAC Transforming Growth Factor Beta 1 Sales by Region (2017-2022) & (K Units)

Table 43. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region (2017-2022)

Table 44. APAC Transforming Growth Factor Beta 1 Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Region (2017-2022)

Table 46. APAC Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)

Table 47. APAC Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)

Table 48. APAC Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)

Table 49. APAC Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)

Table 50. Europe Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)

Table 51. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2017-2022)

Table 52. Europe Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2017-2022)

Table 54. Europe Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)

Table 55. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)

Table 56. Europe Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)

Table 57. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Transforming Growth Factor Beta 1 Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Transforming Growth Factor Beta 1 Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Transforming Growth Factor Beta 1

Table 67. Key Market Challenges & Risks of Transforming Growth Factor Beta 1

Table 68. Key Industry Trends of Transforming Growth Factor Beta 1

Table 69. Transforming Growth Factor Beta 1 Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Transforming Growth Factor Beta 1 Distributors List

Table 72. Transforming Growth Factor Beta 1 Customer List

Table 73. Global Transforming Growth Factor Beta 1 Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Transforming Growth Factor Beta 1 Sales Market Forecast by Region

Table 75. Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Transforming Growth Factor Beta 1 Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Transforming Growth Factor Beta 1 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Transforming Growth Factor Beta 1 Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Transforming Growth Factor Beta 1 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Transforming Growth Factor Beta 1 Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Transforming Growth Factor Beta 1 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Transforming Growth Factor Beta 1 Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Application (2023-2028)

Table 93. Roche Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 94. Roche Transforming Growth Factor Beta 1 Product Offered

Table 95. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Roche Main Business

Table 97. Roche Latest Developments

Table 98. Shionogi Ltd Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 99. Shionogi Ltd Transforming Growth Factor Beta 1 Product Offered

Table 100. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Shionogi Ltd Main Business

Table 102. Shionogi Ltd Latest Developments

Table 103. Acceleron Pharma Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 104. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product Offered

Table 105. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Acceleron Pharma Inc Main Business

Table 107. Acceleron Pharma Inc Latest Developments

Table 108. Genzyme Corp Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 109. Genzyme Corp Transforming Growth Factor Beta 1 Product Offered

Table 110. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Genzyme Corp Main Business

Table 112. Genzyme Corp Latest Developments

Table 113. Isarna Therapeutics GmbH Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 114. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product Offered

Table 115. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Isarna Therapeutics GmbH Main Business

Table 117. Isarna Therapeutics GmbH Latest Developments

Table 118. Scholar Rock Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 119. Scholar Rock Transforming Growth Factor Beta 1 Product Offered

Table 120. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Scholar Rock Main Business

Table 122. Scholar Rock Latest Developments

Table 123. Sirnaomics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 124. Sirnaomics Inc Transforming Growth Factor Beta 1 Product Offered

Table 125. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Sirnaomics Inc Main Business

Table 127. Sirnaomics Inc Latest Developments

Table 128. Eli Lilly and Co Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 129. Eli Lilly and Co Transforming Growth Factor Beta 1 Product Offered

Table 130. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Eli Lilly and Co Main Business

Table 132. Eli Lilly and Co Latest Developments

Table 133. Formation Biologics Inc Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 134. Formation Biologics Inc Transforming Growth Factor Beta 1 Product Offered

Table 135. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Formation Biologics Inc Main Business

Table 137. Formation Biologics Inc Latest Developments

Table 138. Novartis AG Basic Information, Transforming Growth Factor Beta 1 Manufacturing Base, Sales Area and Its Competitors

Table 139. Novartis AG Transforming Growth Factor Beta 1 Product Offered

Table 140. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Novartis AG Main Business

Table 142. Novartis AG Latest Developments

List of Figures

Figure 1. Picture of Transforming Growth Factor Beta 1

Figure 2. Transforming Growth Factor Beta 1 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Transforming Growth Factor Beta 1 Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Transforming Growth Factor Beta 1 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Transforming Growth Factor Beta 1 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Pirfenidone

Figure 10. Product Picture of Galunisertib

Figure 11. Product Picture of Others

Figure 12. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2021

Figure 13. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2017-2022)

Figure 14. Transforming Growth Factor Beta 1 Consumed in IPF

Figure 15. Global Transforming Growth Factor Beta 1 Market: IPF (2017-2022) & (K Units)

Figure 16. Transforming Growth Factor Beta 1 Consumed in Cancer

Figure 17. Global Transforming Growth Factor Beta 1 Market: Cancer (2017-2022) & (K Units)

Figure 18. Transforming Growth Factor Beta 1 Consumed in Others

Figure 19. Global Transforming Growth Factor Beta 1 Market: Others (2017-2022) & (K Units)

Figure 20. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2017-2022)

Figure 21. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application in 2021

Figure 22. Transforming Growth Factor Beta 1 Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Transforming Growth Factor Beta 1 Revenue Market Share by Company in 2021

Figure 24. Global Transforming Growth Factor Beta 1 Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Transforming Growth Factor Beta 1 Revenue Market Share by Geographic Region in 2021

Figure 26. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2017-2022)

Figure 27. Global Transforming Growth Factor Beta 1 Revenue Market Share by Country/Region in 2021

Figure 28. Americas Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)

Figure 29. Americas Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)

Figure 30. APAC Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)

Figure 31. APAC Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)

Figure 32. Europe Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)

Figure 33. Europe Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Transforming Growth Factor Beta 1 Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Transforming Growth Factor Beta 1 Revenue 2017-2022 ($ Millions)

Figure 36. Americas Transforming Growth Factor Beta 1 Sales Market Share by Country in 2021

Figure 37. Americas Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2021

Figure 38. United States Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Transforming Growth Factor Beta 1 Sales Market Share by Region in 2021

Figure 43. APAC Transforming Growth Factor Beta 1 Revenue Market Share by Regions in 2021

Figure 44. China Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country in 2021

Figure 51. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2021

Figure 52. Germany Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Transforming Growth Factor Beta 1 Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2021

Figure 59. Egypt Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Transforming Growth Factor Beta 1 Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1 in 2021

Figure 65. Manufacturing Process Analysis of Transforming Growth Factor Beta 1

Figure 66. Industry Chain Structure of Transforming Growth Factor Beta 1

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390